Explore the latest insights on Medicare and Social Security processing delays and policy updates, including expert advice from Romy & Associates on managing your healthcare plans effectively.

Explore the new executive order signed by President Trump aimed at reducing drug prices and improving Medicare transparency. Understand its impact on healthcare costs and policy continuity in U.S. healthcare.

The 2023 Mobility Device User Survey highlights significant challenges faced by Americans relying on mobility devices, underlining the need for policy reform.

President Trump signs an executive order to lower U.S. prescription drug prices, amending key Medicare negotiations. Learn how this could impact the healthcare and insurance sectors.

CHI St. Vincent renews agreement with UnitedHealthcare for in-network patient access, enhancing healthcare delivery in Arkansas and ensuring quality services.

CMS finalizes a 5.1% increase for Medicare Advantage payments in 2026, signaling growth and new consumer protections for beneficiaries.

Explore how the 2024 Medicare Advantage Final Rule impacts hospitals and the strategic adjustments necessary for compliance. Learn about the importance of the Two-Midnight Rule, enhanced provider-payer collaborations, and the role of technology in optimizing healthcare outcomes.

Discover Dr. Mehmet Oz's agenda for CMS emphasizing price transparency, fraud prevention, and healthcare modernization under the Make America Healthy Again initiative.

Explore how MU Health Care exceeded their financial expectations while facing negotiations with Anthem over Medicare Advantage plans, highlighting the evolving dynamics between healthcare providers and insurance carriers.

Mehmet Oz has commenced his leadership at CMS with plans for healthcare modernization and a crackdown on fraud. These changes aim to enhance care for America's most vulnerable groups while aligning Medicaid spending with its fundamental aims.